The Challenge
G&W Laboratories, a New Jersey-based generic pharmaceutical products manufacturer, retained PharmaBioSource Realty, LLC as its exclusive real estate broker to market and sell its 220,000-square-foot oral solid and oral liquid dosage manufacturing and packaging facility in Sellersville, Pennsylvania. The divestiture was part of G&W’s strategic manufacturing network consolidation program. Located approximately 35 miles north of Philadelphia, the site offered a strategic buyer the opportunity to acquire a world-class tablet and capsule manufacturing asset at a discount to replacement cost, with a substantial reduction in time to market.
The Solution
PharmaBioSource Realty engaged the pharmaceutical and biotech industry to market and sell the Sellersville facility to a strategic acquirer. We drew on real estate and technical expertise and our extensive contacts within the pharmaceutical industry to identify qualified potential buyers for the site.
Services provided by the PharmaBioSource Realty team:
- Facility and equipment assessments
- Prep for sale
- Creation of introductory project teaser
- Target identification and marketing
- Support in developing a data room
- Managed confidentiality agreements
- Hosted site visits and meetings with G&W and buyer management
- Supported buyer due diligence
- Contract documents
- Deal structure and negotiations
- Closing
The Results
PharmaBioSource Realty identified Piramal Pharma Solutions, a global pharmaceutical contract development and manufacturing organization (CDMO), as the acquirer.
What We Did
Real Estate Brokerage
Facility Divestiture